In this episode, we talk about ADCs or antibody-drug conjugates with Ilaria Contis, a VP at ADC Therapeutics. This Swiss company is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs). It is known for being a one-stop-shop for ADC development, handling everything from research to selling their products.
Ilaria shares about how ADCs (antibody-drug conjugates) are transforming cancer treatment, opportunities and challenges in ADC tech, and why global experience matters in pharma careers.
Here's what you are in for:
01:14 – Getting Into Medicine
09:56 – Interest in ADCs
11:25 – ADC’s History and Recent Developments
21:13 – Business Development Perspective on ADCs
25:38 – Expanding Beyond Hematology
31:02 – US vs. Europe in Pharma and Biotech Careers
40:28 – Inspiring the Next Generation
Watch full episodes on:
- Spotify: https://open.spotify.com/episode/1b0pFtJLbAlcDSSHJMeEpA?si=7346249dc5fe42bc
- Apple: https://podcasts.apple.com/us/podcast/ilaria-conti-vp-adc-therapeutics-female-leadership/id1736051162?i=1000650319959
ABOUT ILARIA
Ilaria Contis is a pharmaceutical developer from Tuscany, Italy, where she spent her childhood. With a background in medicine and a strong drive for research, Ilaria was inspired by the groundbreaking work of Nobel Prize laureate Rita Levi-Montalcini to pursue a career in the medical field. Her journey led her to the United States, where she immersed herself in clinical research and eventually found her niche in the pharmaceutical industry, particularly focusing on the development of Antibody-Drug Conjugates (ADCs).
Connect with Ilaria:
- LinkedIn: https://www.linkedin.com/in/ilaria-conti-581bb06/
- Website: https://www.adctherapeutics.com/
ABOUT CHARLES
Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.
He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.
In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.
Connect with Charles:
LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
Click here for more details.
